(5-(N,N-Diethylsulfamoyl)-2-methylphenyl)boronic acid, 98%, 1g

4-Methoxy-2-(2-methoxyethoxy)benzoic acid, 95%, 1g

Thalidomide-O-amido-PEG3-C2-NH2 (TFA), 500mg

3-Methyl-[1,2,4]oxadiazole-5-carboxylic acid ethylester, 90.0%, 25g

(Pentafluorophenyl)diphenylphosphine, 97%, 5g

N,O-Bis(trifluoroacetyl)hydroxylamine>98.0%(T)5g

1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone, 99.00%, 500g

N,N-Dimethyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride, 97%, 250mg

5-(BOC-AMINO)-2-BROMO-THIAZOLE-4-CARBOXYLIC ACID, 97.0%, 1g

Chromium granules, min. 99.95%, 1-5 mm, 50 g, glass packaging

Ethyl 2,2,2-triethoxyacetate, 95.0%, 5g

N-Methyl-N-nitrosourethane>95.0%(GC)5g

Ethyl 4,6-dichloro-5-nitronicotinate, 95.0%, 10g